Weiss Multi-Strategy Advisers’s Fennec Pharmaceuticals FENC Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24,237	Closed	-$147K	–	714
2020 Q3	$147K	Sell	24,237 -886	-4%	-$6.25K	﹤0.01%	536
2020 Q2	$210K	Sell	25,123 -316	-1%	-$2.35K	0.01%	515
2020 Q1	$151K	Sell	25,439 -1,061	-4%	-$6.92K	0.01%	394
2019 Q4	$172K	Buy	26,500 +1,500	+6%	+$8.06K	﹤0.01%	573
2019 Q3	$120K	Hold	25,000	–	–	﹤0.01%	554
2019 Q2	$100K	Hold	25,000	–	–	﹤0.01%	477
2019 Q1	$121K	Hold	25,000	–	–	﹤0.01%	487
2018 Q4	$160K	Buy	+25,000	New	+$175K	0.01%	419

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Weiss Multi-Strategy Advisers's FENC Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Fennec Pharmaceuticals (FENC) in Q4 2020, closing a stake of 24,237 shares — an estimated $147K sold.

Weiss Multi-Strategy Advisers first reported a position in FENC in Q4 2018 and held it in 8 quarters. The position peaked at $210K in Q2 2020. 52 funds tracked by Wall St. Rank hold FENC as of Q4 2020.

Weiss Multi-Strategy Advisers reported no remaining Fennec Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 24,237 Fennec Pharmaceuticals shares in Q4 2020, an estimated $147K.
Weiss Multi-Strategy Advisers first reported a position in Fennec Pharmaceuticals in Q4 2018 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Fennec Pharmaceuticals position peaked at $210K in Q2 2020.
52 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.